Global Transplant Diagnostics Market is Estimated to Value Over USD 5.1 Billion by 2026 End

  • 26 Sep 2019

Global Transplant Diagnostics Market is estimated to value over USD 5.1 billion by 2026 end and register a CAGR of over 6.4% during the forecast period 2019 to 2026

 

The factors steering the global transplant diagnostics market growth are rising adoption of transplant diagnostic techniques in respective research studies and increasing focus on early and effective profiling of patients during the process of organ transplantation. The transplant diagnostics market is bifurcated into software and services, instruments, reagents and consumables. The reagents and consumables segment held the largest global transplant diagnostics market share in 2018. 

 

Molecular Assays Technology Segment is Predicted to Record the Highest CAGR Over the Forecast Period 

The market is bifurcated based on the type of technology as non-molecular assays and molecular assays. The segment that is anticipated to record a high CAGR value over the forecast period is the molecular assay technology segment. Factors such as raising private and public investments to bolster the development of products, its variety of applications related to profiling the patients and rising clinical evidence in order to establish the effectiveness of molecular assay methods are steering the segment growth.

 

The solid-organ transplantation segment is projected to hold the largest market share during the forecast period. The reassuring regulations of the government to increase the donation of organs across key healthcare markets, an increasing number of persistent disorders diseases that results into transplantation and current advancements in technology are the crucial factors expanding the global transplant diagnostics market size.

 

Regionally, the market is fragmented into Europe, Asia Pacific, North America and the rest of the world. The North American region holds the largest market share and this can be credited to the consistent innovation of transplant diagnostic products along with current technological advancements in proteomics and genomics, recently discovered genetic biomarkers and their role in testing immunoassays and growing incidences of communicable and persistent diseases.

 

Key players included in the global transplant diagnostics industry are Becton, Dickinson and Co., Biofortuna, Biomerieux SA, Bio-Rad Laboratories, Caredx, F.Hoffman-La Roche Ltd., Gendx, Hologic, illumine, Immucor, Luminex, Merck KGaA, Omixon, Qiagen, Thermo Fisher Scientific.

 

Global Transplant Diagnostics Market Segmentation:

By Product and Services

  • Reagents
  • Instruments
  • Software and Services

 

By Technology

  • Molecular Assays
  1. PCR-Based Molecular Assays
    1. Real-Time PCR
    2. Sequence-Specifier Primer-PCR
    3. Sequence-Specific Oligonucleotide-PCR
    4. Others PCR-Based Molecular Assays
  2. Sequence-Based Molecular Assays
    1. Sanger Sequencing 
    2. Next-Generation Sequencing
    3. Others Sequencing Molecular Assays
  • Non-Molecular Assays

 

 By Transplant Type

  • Solid Organ Transplant 
    1. Kidney Transplant
    2. Liver Transplant
    3. Heart Transplant
    4. Lung Transplant
    5. Pancreas Transplant
    6. Other Organ Transplantations
  • Stem Cell Transplant
  • Soft Tissue Transplant

 

By Application

  • Diagnostic Applications
    1. Pre-Transplantation Diagnostics
      1. Infectious Disease Testing
      2. Histocompatibility Testing
      3. Blood Profiling
    2. Post-Transplantation Diagnostics
  • Research Applications

 

By End User

  • Independent Reference Laboratories
  • Hospitals & Transplant Centres
  • Research Laboratories & Academic Institutes

 

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

  

FutureWise Key Takeaways:

• Growth prospects

• SWOT analysis 

• Key trends 

• Key data-points affecting market growth 

 

Objectives of the Study:

  • To provide with an exhaustive analysis on the global transplant diagnostics market by product and services, by technology, by transplant type, by application, by end user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market 
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies

 

Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com